Physician profile
Robert Todd Riggio
NPI 1952751331
$31,413.63
in general payments reported to CMS, 2019-2025
11 companies · $513 in 2025
The $513 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $17K · 2023: $14K · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $721 · Education: $60.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,860.96 |
| Food and Beverage | $721.16 |
| Education | $60.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ceribell, INC. | $30,882.24 | 2021-2025 | Ceribell Rapid Response Eeg, Pocket Eeg Device |
| Abbvie INC. | $197.65 | 2023-2025 | Botox |
| Csl Behring | $60.42 | 2025 | Privigen |
| Alexion Pharmaceuticals, INC. | $59.19 | 2025 | Ultomiris |
| Genzyme Corporation | $55.91 | 2025 | |
| Biogen, INC. | $53.13 | 2025 | Vumerity, Tysabri |
| Eisai INC. | $27.18 | 2025 | |
| Emd Serono, INC. | $25.00 | 2023 | Mavenclad |
| Philips North America LLC | $20.19 | 2023 | |
| Ns Pharma, INC. | $18.01 | 2025 | Viltepso |
| Ucb, INC. | $14.71 | 2025 | Briviact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Riggio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.